AI Insight
Researchers at the University of South Florida have identified a new vulnerability in Plasmodium vivax, a malaria parasite responsible for infections across Central and South America and Southeast Asia. This discovery may lead to vaccine development that could prevent the parasite from establishing dormant liver-stage infections, which can reactivate years after initial infection.
Why it matters
P. vivax causes relapsing malaria because it can remain dormant in the liver for extended periods before reactivating. Identifying this vulnerability could enable development of vaccines or treatments that block liver-stage infection, potentially preventing the recurring infections that make P. vivax particularly difficult to eliminate.
Understand the Science
University of South Florida researchers have discovered a previously unknown vulnerability in Plasmodium vivax (P. vivax), a malaria parasite that infects millions of people in Central and South America and Southeast Asia.
Source: Malaria parasite can reawaken after years: New vaccine target may block liver infection